TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Investor Investigation Concerning Potential Wrongdoing Announced

  • If you purchased shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

August 4, 2015 (Update) - On July 27, 2015, AMAG Pharmaceuticals, Inc stated in its 10Q report that on July 20, 2015, the Federal Trade Commission (the 'FTC') notified AMAG Pharmaceuticals, Inc that it is conducting an investigation with respect to Makena or any hydroxyprogesterone caproate product. AMAG Pharmaceuticals, Inc said that the FTC noted that the existence of the investigat...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)